RxDoctor Payments DataLook up a doctor →

Gary Reiss, MD

Gastroenterology · Marrero, LANPI 1568666543

Payments from drug & device makers

$9,977,751in general payments, 2019–2025

Across 2,895 payments — averaging $3446.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2.3M
  • Intercept Pharmaceuticals, Inc.$1M
  • Alnylam Pharmaceuticals Inc.$794K
  • Ironwood Pharmaceuticals, Inc$669K
  • Vanda Pharmaceuticals Inc.$620K
  • Regeneron$587K
  • plus $4M from 54 others
$21,388in research payments, 2019–2025

Across 5 payments — averaging $4277.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$12K
  • Bausch Health US, LLC$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)362$2,280,424
Intercept Pharmaceuticals, Inc.80$1,035,675
Alnylam Pharmaceuticals Inc.145$794,010
Ironwood Pharmaceuticals, Inc29$669,459
Vanda Pharmaceuticals Inc.85$619,925
Regeneron890$587,372
Eli Lilly8$491,513
GSK116$454,506
Pfizer47$385,127
Boehringer Ingelheim7$296,462
Braintree Laboratories, Inc.39$250,761
Merck7$249,295
Takeda Pharmaceuticals U.S.A., Inc.95$240,290
Bausch Health US, LLC51$230,649
Madrigal Pharmaceuticals57$213,826
Senseonics, Incorporated60$180,969
Janssen Research & Development, LLC78$157,488
Novo Nordisk AS292$155,412
Boehringer Ingelheim International GmbH71$125,092
AstraZeneca14$110,011
Chugai Pharmaceutical Co., Ltd.23$94,564
E.r. Squibb & Sons, L.L.C.5$81,099
Biogen1$44,692
Phathom Pharmaceuticals, Inc.25$38,948
Covidien LP45$32,506
Teva Pharmaceuticals USA, Inc.14$28,784
Novartis3$25,505
Exeltis, USA Inc.19$22,121
Ipsen Bioscience Inc.9$21,648
GI Supply, Inc.6$16,923
Boehringer Ingelheim RCV GmbH & Co KG33$15,818
Medtronic24$8,889
Bristol Myers Squibb7$7,052
Micro-tech Endoscopy USA, Inc.3$3,500
Boston Scientific14$3,269
Laborie Medical Technologies Corp.16$1,014
Pentax Of America, Inc.5$464
Ardelyx, Inc.19$431
Anx Robotica Corp2$272
Ambu Inc.2$252
Johnson & Johnson16$250
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC14$228
Sanofi10$201
Celltrion USA Inc.11$190
Angiodynamics, Inc.1$161
Mallinckrodt Hospital Products Inc.2$136
Gilead6$121
Regeneron Healthcare Solutions, Inc.4$91
Ipsen Biopharmaceuticals, Inc3$56
Organon3$53
Fujifilm Healthcare Americas Corporation3$49
Conmed Corporation1$36
Lilly USA, LLC2$32
Daiichi Sankyo Inc.1$29
Novo Nordisk1$19
Acell, Inc.1$19
Evoke Pharma, Inc.1$17
Redhill Biopharma Inc.1$17
Aimmune Therapeutics, Inc.1$16
Amgen1$14

How this compares

$9,977,751 in reported general payments places this provider in the 95th percentile of 254 gastroenterology providers in Louisiana.

See all gastroenterology providers in Louisiana →

Medicare billing

Part B allowed, 2024
$95,369
Medicare patients
313
Services billed
871

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Marrero

See the full list for Louisiana →

Where these figures come from

Is this you, or does something look wrong? →